Hina Patel

Vice President, Global Patient Safety Science, Revolution Medicines

Hina leads Global Patient Safety Science at Revolution Medicines, the oncology company developing RAS-targeted therapies. She was previously Executive Director of Safety Science at Erasca and Principal Director of Product Development Safety in Oncology at Genentech.

Events Hina Patel has spoken at

Pharmacovigilance Europe Congress 2027 19 May 2027 – 20 May 2027